First shakeup In Upton Regime: Peters Moves Out As DCCP Head To Become “Special Assistant”
In Brief: Carcinogenesis: Does The Promise Justify The Effort? Task Force Attempts To Find Out
New Research Projects Proposed For Immunology
Centers Structures, Governance, Funding, Review considered By NCI, NCAB, Center Directors
New Cooperative Group Funded
NCI Appropriations Still Hung Up
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ - One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- NCI’s Philip Castle on NHS-Galleri results: “I’m sorry that it didn’t work, but it keeps the national conversation going.”
Castle is “disappointed” by Galleri results but not discouraged by implications for MCDs
